secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIODESIX INC (BDSX)
CIK:        0001439725
Form:       8-K
Filed at:   2022-01-04T23:59:59+00:00
Accession:  0000950170-22-000036
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biodesix raises ~$16.3M via ATM equity sale, repays $20M of term loan with SVB
------------------------------------------------------------------------------

- Raised ~$16.3M from sale of 3,756,994 common shares in ATM offering on Dec 30, 2021.
- Entered Consent and Second Amendment to $30M 2021 Term Loan with Silicon Valley Bank on Dec 31, 2021.
- Repaid $20M in outstanding principal on Dec 31; $600,000 prepayment fee waived.
- Amendment consents to $4.6M milestone payment under Integrated Diagnostics APA in Jan 2022.
- Company cites improved financial flexibility to advance strategic growth objectives.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1439725/000095017022000036/0000950170-22-000036-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1439725/000095017022000036/bdsx-20211230.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-000036

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer